Woodline Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Woodline Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-90,435	Closed	-$8.8M	–	288
2020 Q3	$8.8M	Sell	90,435 -22,350	-20%	-$2.57M	0.29%	93
2020 Q2	$13.8M	Sell	112,785 -105,740	-48%	-$12M	0.55%	58
2020 Q1	$19.1M	Buy	218,525 +101,159	+86%	+$10.7M	1.37%	20
2019 Q4	$12.3M	Buy	+117,366	New	+$13.2M	0.5%	64

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Woodline Partners's GWPH Position: Q4 2020 in Review

Woodline Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 90,435 shares — an estimated $8.8M sold.

Woodline Partners first reported a position in GWPH in Q4 2019 and held it in 4 quarters. The position peaked at $19.1M in Q1 2020. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

Woodline Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
Woodline Partners sold 90,435 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $8.8M.
Woodline Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 4 quarters.
Woodline Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $19.1M in Q1 2020.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Woodline Partners's 13F filing for Q4 2020, filed 16 Feb 2021.